We submit herewith statement of Variation/deviation of utilization of Funds raised by way of Preferential Allotment on 26.03.2026

CIN L33112MP1985PLC003039 RAAJ MEDISAFE INDIA LIMITED Regd. Office: 75/2 and 3, Industrial Area, Maksi Road, Ujjain-456010 Email: raajmedisafe@gmail.com, Website: www.raajmedisafeindia.com Phone: 0734 2518989 2513349 August 12, 2026 The Corporate Relationship Department BSE Ltd. Phiroze Jeejeebhoy Towers, Dalal Street MUMBAI – 400001 Scrip Code 524502 Dear Sir, Sub. Subject: Statement of Deviation or Variation in utilization of funds raised through Preferential Issue under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the Quarter ended June 30, 2026 Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation or variation in utilization of funds raised through Preferential Issue by the Company, for the quarter ended June 30, 2026, reviewed by the Audit Committee at its meeting held on August 12, 2026 Please take the above information on record. Thanking you, Yours faithfully, FOR RAAJ MEDISAFE INDIA LIMITED Arpit Bangur Chairman & Managing Director DIN:02600716 Encls: As stated CIN L33112MP1985PLC003039 RAAJ MEDISAFE INDIA LIMITED Regd. Office: 75/2 and 3, Industrial Area, Maksi Road, Ujjain-456010 Email: raajmedisafe@gmail.com, Website: www.raajmedisafeindia.com Phone: 0734 2518989 2513349 STATEMENT OF DEVIATION / VARIATION IN UTILIZATION OF FUNDS RAISED (Pursuant to Regulation 32(1), (2) and (3) of SEBI (LODR) Regulation, 2015) Name of listed entity Raaj Medisafe India Limited Mode of Fund Raising Preferential Issue Date of Raising Funds 26TH March, 2026 Amount Raised Rs. 18,01,25,000 Report filed for Quarter ended June 30, 2026 Monitoring Agency N.A. Monitoring Agency Name, if applicable N.A. Is there a Deviation / Variation in use of funds No raised If yes, whether the same is pursuant to change in NA terms of a contract or objects, which was approvedby the shareholders If Yes, Date of shareholder Approval NA Explanation for the Deviation / Variation NA Comments of the Audit Committee after review None Comments of the auditors, if any None Objects for which funds have been raised and The detail are as under: wherethere has been a deviation, in the following table: Original Object Modifie Original Modified Funds Amount of Remarks dObject, Allocatio allocation Utilise Deviation/ ifany ifany n , if any d Variation forthe quarter according applicable object Acquisition of plant, machinery, and the business operations of Fabrizo Industries Private Limited, specifically relating to its Goa- based manufacturing unit engaged in the Not Applicable as there is no Deviation/ production of liquor caps and related closure variation in Utilization of funds. products, Company’s expansion plans, including manufacturing capacity enhancement in hygiene and related business and meeting working capital requirements and general corporate purposes. Deviation or variation could mean: a) Deviation in the objects or purposes for which the funds have been raised; or b) Deviation in the amount of funds actually utilized as against what was originally disclosed; or c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. FOR RAAJ MEDISAFE INDIA LIMITED Arpit Bangur Chairman & Managing Director DIN:02600716